Page Banner

United States Department of Agriculture

Agricultural Research Service


Location: Human Nutrition Research Center on Aging

2012 Annual Report

1a.Objectives (from AD-416):
1. Determine the impact of mandatory food folic acid fortification in the United States. 2. Determine the interrelationships between B vitamin status, methionine intake, genetic polymorphism and plasma homocysteine. 3. Determine the hereditary association of plasma homocysteine and vitamin status. 4. Determine the biochemical, pathological and functional impact of nutritional and genetic disruptions of one-carbon metabolism, in animal models of age-related vascular and neurological dysfunction, with emphasis on the roles of B vitamins, homocysteine and methionine in tissue-specific susceptibility to disease.

1b.Approach (from AD-416):
In this project, we will use multiple approaches to study the biochemistry and molecular biology of the interaction of B vitamins with each other and their role in modulating the risk for age-related pathologies, and the genetic factors that influence these interactions. We will determine the interaction between vitamin B12 status, unmetabolized folic acid, methyl tetrahydrofolate and folic acid intake in relation to cognitive impairment, bone mineral density, cardiovascular disease risk, diabetes and cancer. For this purpose, we will measure the unmetabolized folic acid and methyl folate in the plasma of participants in National Health and Nutrition Examination Survey 1999-2002 and Framingham Heart Study (FHS) Offspring cohorts, measure plasma concentration of methylmalonic acid (MMA) in FHS Offspring cycle 7 examinations and use plasma MMA as a marker of vitamin B12 status. We will also use an animal model of vitamin B12 deficiency to characterize the biochemical and hematological effect of high folate status under vitamin B12 deficiency. The gene-nutrient interaction between folate and the 677C>T polymorphism of the methylene tetrahydrofolate reductase (MTHFR) gene will be studied by determining the changes in DNA methylation and gene expression using microarray analysis after a 3-month dietary supplementation of 400µg/day folic acid in individuals homozygous for the C and T alleles of the MTHFR polymorphism. The heritability of plasma homocysteine concentration in FHS cohort will be determined by comparing data on plasma homocysteine from 3 generations of FHS participants in the context of their plasma folate and vitamin B12 status, and by determining the association between polymorphisms in genes that influence methylation of homocysteine including those involved in uptake of vitamin B12, and plasma homocysteine concentration.

3.Progress Report:
This progress report includes the work of one subordinate project at the HNRCA funded through a Specific Cooperative Agreement with TUFTS UNIVERSITY. For further information and progress reports, see 1950-51000-076-01S (The role of B vitamins and one carbon metabolism in aging).

1. LAB: Vitamin metabolism: Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of US Adults. Low pyridoxal 5’phosphate (functional form of vitamin B-6) concentration in blood has been associated with various inflammatory diseases, including cardiovascular disease, rheumatoid arthritis, inflammatory bowel disease, and diabetes. Presence of inflammation even in the absence of a disease can be determined using markers of inflammation in blood. To determine the association between concentration of pyridoxal phosphate in blood and inflammation we created an overall inflammation score using 13 individual markers of inflammation. We examined the association between pyridoxal phosphate concentration in plasma and inflammation score among 2229 participants of Framingham Heart Study. Blood concentrations of pyridoxal phosphate were lower among individuals with a high inflammation score when compared with those who have low inflammation score. These relationships persisted after accounting for vitamin B-6 ingestion showing that these results are not due to differences in vitamin B-6 in the diet. These results suggest that during inflammation there is a higher demand for vitamin B-6 and it may be used for the processes of inflammation.

2. LAB: Vitamin metabolism: Risk of retinoblastoma is associated with a maternal polymorphism in dihydrofolate reductase (DHFR) and prenatal folic acid intake. Maternal intake of naturally occurring folate from vegetables during pregnancy is associated with lower risk of retinoblastoma (cancer of the eye) in offspring. ARS-funded researchers at JM USDA HNRCA at Tufts University in collaboration with researchers at Columbia University, New York, Hospital Infantil de Mexico (HIM), Mexico, National Institute of Public Health, Mexico and Mexican Institute of Social Security, Mexico examined the association between retinoblastoma risk and maternal genetic variations in genes for 2 enzymes that carry out reactions involving folate, methylene tetrahydrofolate reductase and dihydrofolate reductase. 103 mothers of children with newly diagnosed retinoblastoma and 97 mothers who had healthy children from central Mexico were enrolled in the study. The risk of having a child with retinoblastoma was associated with maternal genetic variation in dihydrofolate reductase and the risk was elevated significantly among those who reported taking folic acid supplements during pregnancy. Dihydrofolate reductase is necessary for converting synthetic folic acid into biological folate. The genetic variation in dihydrofolate reductase decreases the ability of the body to convert folic acid. Prenatal ingestion of synthetic folic acid supplements may be associated with increased risk for early childhood cancer in a genetically susceptible subset of the population.

Review Publications
Orjuela, M., Cabrera-Munoz, L., Paul, L., Ramirez-Ortiz, M., Liu, X., Mejia-Rodriguez, F., Medina-Sanson, A., Diaz-Carreno, S., Suen, I., Selhub, J. 2012. Risk of retinoblastoma is associated with a maternal polymorphism in dihydrofolatereductase (DHFR) and prenatal folic acid intake. CANCER. DOI: 10.1002/cncr.27621.

Pikula, A., Beiser, A.S., Decarli, C., Himali, J.J., Debette, S., Au, R., Selhub, J., Toffler, G.H., Wang, T.J., Meigs, J.B. 2012. Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the framingham offspring study. Circulation. 125(17):21000-2107.

Lee, J., Wei, E.K., Fuchs, C.S., Hunter, D.J., Lee, I., Selhub, J., Stampfer, M.J., Willett, W.C., Ma, J., Giovannucci, E. 2012. Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes and Control. 23(4):537-545.

Selhub, J., Wu, K., Platz, E., Willet, W., Fuchs, C., Rosner, B., Hunter, D., Giovannucci, E. 2009. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. American Journal of Clinical Nutrition. 90(6):1623-1631.

Last Modified: 4/21/2014
Footer Content Back to Top of Page